Hier finden Sie den Zugang zur Notfallseite, Kontaktinformationen, Barrierefreiheits-Einstellungen, die Sprachwahl und die Suchfunktion.

Navigation öffnen



CCCC/DKTK Technical Seminar: Proteogenomic approaches to Intratumor Heterogeneity: the need for integrated workflows to understand solid tumor ecosystems

Zurück zur Übersicht

Sie befinden sich hier:

Veranstaltung ausschließlich für Fachpublikum

Rainer Bläsius, PhD

Dear Colleagues,

This time, we are pleased to announce a special technical seminar with Dr. Rainer Bläsius, BD Technologies, Heidelberg.

CCCC/DKTK Technical Seminar
Proteogenomic approaches to Intratumor Heterogeneity: the need for integrated workflows to understand solid tumor ecosystems

The current view of tumor tissue development includes a cellular ecosystem as integral model to understanding the basic cancer biology on which clinical progress needs to be based. We have developed a workflow which analyzes cell subpopulations and single cells in a multi-omic approach. Our data suggests a division of labor between cancer cell subpopulations and offers a blueprint for inclusion of all cells of the tumor and its microenvironment towards a deeper understanding of cancer biology and ultimately improved cancer patient care.

Date:    November 28, 2016, 3 - 5 p.m.
Venue: CharitéCrossOver (CCO) | Auditorium
             Campus Charité Mitte | Virchowweg 6 | 10117 Berlin


Dr. Blaesius received his PhD in Biochemistry from the Freie Universität in Berlin. After continuing his graduate work on G-Protein-Coupled Receptor Signaling in his postdoctoral studies at UNC Chapel Hill, he developed GPCR-based assays for drug discovery as a Senior Scientist at Karobio, USA. Subsequently, he joined BD Technologies as a Senior Scientist and led the development of antibodies for cancer screening and staging assays. Under his guidance, a team of scientists developed a novel screening platform for Stem Cells which was used for collaborations with various Pharmaceutical companies as well as BD-internal product development in support of Stem Cell Therapies. In his present position as Technology Manager, Dr. Blaesius leads a project directed at using Flow Cytometry for Solid Tumor Tissues and Fluorescence ActivatedCell Sorting (BD FACS™) to enable Single Cell Molecular analysis of Solid Cancers.

We would like to cordially invite you to join us for an afternoon of exciting discussions and look very much forward to welcoming you there.

Furthermore, please feel free to distribute this announcement to people you think would be interested.

Best regards,

Prof. Ulrich Keilholz                                     Prof. Carsten Denkert                                                      
Acting Director                                            Translational Tumor Research and Molecular Pathology
Charité Comprehensive Cancer Center      Institute of Pathology, Charité – Universitätsmedizin Berlin

Attendance free



Rainer Bläsius, PhD
Manager R&D, Genomic Sciences
BD Technologies


Charité Comprehensive Cancer Center (CCCC)
DKTK Partner site Berlin


November 28, 2016
3 - 5 p.m.


Charité Campus Mitte (CCM)
CharitéCrossOver (CCO
Charitéplatz 1
10117 Berlin



E-Mail: cccc-fortbildung(at)

Zurück zur Übersicht